Navigation Links
Laura Bush in Senegal for Anti-HIV/AIDS, Malaria Campaigns

The First Lady of the United States, Laura Bush arrived in the Senegalese capital of Dakar Monday at the start of a four-nation Africa tour to bolster the US government's anti AIDS and malaria strategies.

She was met at the airport by President Abdoulaye Wade's wife Viviane.

From Senegal she is due to travel to nearby Mali then Zambia and Mozambique during a five-day long trip to the continent which will also focus on education and women's empowerment.

She is due to visit US-funded 15 billion dollar projects under the President's Emergency Program for AIDS Relief (PEPFAR), which was launched by President George W. Bush in 2003 and is due to expire in September 2008.

Bush last month asked Congress to set aside 30 billion dollars over five years to fight AIDS worldwide.

Sub-Saharan Africa remains by far the worst-affected region and is home to two-thirds of all people living with HIV.

In 2005 Bush launched a anti-malaria campaign aimed at funding pesticide spraying, handouts of bed nets and provision of anti-malarial drugs.

Malaria remains a leading killer worldwide, claiming more than one million lives every year, most of them in Africa.

The mosquito-borne illness is the number one cause of death in children under the age of five, causing one death every 30 seconds.


'"/>




Page: 1

Related medicine news :

1. Skin Cancer Tumour Removed from Laura Bushs Leg
2. Laura Bush Makes Light of Cancer News
3. Malaria strikes Munger tribals
4. Sponging Cattle betters spraying in eradicating Malaria
5. Gene researchers make Malaria-resistant mosquito
6. More Treatment Options For Malaria
7. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
8. Jharkhand reports 13,000 Malaria cases
9. Researchers Discover Protein That Causes Malaria
10. Malarial gene ascertained
11. Artesunate Is Better For Malaria Than Quinine
Post Your Comments:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 310 Things to do This Summer 21 48398 110 Things to do This Summer 21 48398 210 Things to do This Summer 21 48398 3Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 1Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 2Caribbean coral reefs flattened 8781 1Caribbean coral reefs flattened 8781 2